Price variation analysis of various drugs used for thromboembolic disorders currently available in Indian pharmaceutical market

Abstract

Background Major population in developing countries purchases medicine through out-of-pocket payment thus making them the largest family expenditure item after food. As a result, medicines are unaffordable for large sections of the global population and a major burden on government budgets. In developing country India, price of drugs play a major role in prescribing a drug for treatment. Methods An analytical study was done for comparing price variations among various drugs prescribed in thromboembolic disorders. Indian Drug Review (IDR) (January 2019) and CIMS (October December 2018) was referred to know the maximum and minimum price in INR of drugs in all available strength and dosage forms being manufactured by different companies in India and percentage price variation was calculated. Results Wide variation in the price of several brands of same anticoagulants, fibrinolytics, antiplatelets and their combinations were found in Indian pharmaceutical market. Highest percentage price variation was found for Aspirin 150 mg + Clopidogrel 75 mg Tablet (741.03%) combination. Percentage price variation is >100% for all the different combinations of aspirin + clopidogrel. In single drug, highest percentage price variation was found for Aspirin 100 mg Tablet (435.13%) followed by Aspirin 75 mg Tablet (403.78%), Clopidogrel 75 mg Tablet (275%), Aspirin 50 mg Tablet (221.96 %). In single drug, lowest percentage price variation was found for Eftifibatide 20mg/10 ml injection (1.15%) followed by Tirofiban 5mg/100 ml injection (2.63%), Warfarin 5 mg Tablet (3.23%). Conclusion Steps should be taken by the government towards reduction in price variation among the various brands so as to them affordable and aim to improve the health status of community. This will definitely reduce the economic burden on government. The purpose of “Health for all” can only be achieved by efforts from all stakeholders.

Authors and Affiliations

Neeta J. Kanani

Keywords

Related Articles

Evaluation of analgesic effect of aqueous extract of physalis minima flowers & leaves in albino mice

Background Physalis Minima is a commonly known as Ground cherry or Sun berry. It belongs to the family solanaecia. It is a common species found in India & posses Anti-inflammatory, analgesic antipyretic, Antifertility A...

Plasma lipid profile patterns in oral leukoplakia and oral squamous cell carcinoma

Background Changes in the lipid profile has been reported to be associated with oral cancer and also in cases of oral premalignant lesions and conditions. This study was done to assess the relationship between plasma li...

CNS depressant activity of ethyl acetate leaf extract of Avicennia officinalis in mices

The present study deals with the investigation of the ethyl acetate extracts of Avicennia officinalis leaves was assessed for an effect on the central nervous system (CNS) using neuropharmacological experimental models (...

Role Of Clinical Pharmacist In Identifying The Factors That Influence Medication Non- Adherence And Improvement On Hospitalised Geriatric Non-Adherent Patients

Background- Poor adherence is one of the major factors which alters therapeutic outcome of medication in geriatric patients with chronological diseases. Medication non-adherence is one of the drug related barrier for h...

Evaluation of antipyretic and analgesic activity of methanolic extract of Rivea ornata (roxb.) Leaves

Riveaornatais a climbing or straggling shrub, widely distributed throughout the south Indian region. The juice of this plant is used topically in haemorrhagic diseases and piles. Arial parts of this plant possess anti-in...

Download PDF file
  • EP ID EP648398
  • DOI -
  • Views 55
  • Downloads 0

How To Cite

Neeta J. Kanani (2019). Price variation analysis of various drugs used for thromboembolic disorders currently available in Indian pharmaceutical market. International Journal of Research in Pharmacology & Pharmacotherapeutics (IJRPP), 8(2), 294-301. https://europub.co.uk/articles/-A-648398